EFAI ChestSuite XR Pneumothorax Assessment System

The EFAI ChestSuite XR Pneumothorax Assessment System (EFAI PNXXR v1.0) is a software tool utilizing a deep learning algorithm to analyze adult Posteroanterior (PA) chest X-rays for suspected pneumothorax. Its purpose is to aid clinicians by identifying and flagging these cases within a PACS/workstation environment for prioritized review, thereby enhancing triage efficiency without making standalone diagnostic decisions or directing attention to specific image locations.

The EFAI ChestSuite XR Pneumothorax Assessment System (EFAI PNXXR v1.0) is a radiological computer-assisted triage and notification software designed to assist in the clinical assessment of adult Posteroanterior (PA) view chest X-rays for features suggestive of pneumothorax. Employing deep learning techniques, the system automatically analyzes these X-rays and sends notification messages to the Picture Archiving and Communication System (PACS) or workstation. This facilitates the prioritization of cases with suspicious findings, aiding in triage. Importantly, EFAI PNXXR provides passive notifications and does not mark or direct users’ attention to specific locations on the X-ray, nor are its results intended for standalone clinical decision-making or to rule out pneumothorax. The performance of EFAI PNXXR was evaluated in a retrospective, blinded, multicenter study using 800 anonymized chest X-ray images, comparing it against a predicate device. The study, with ground truth established by three board-certified radiologists, included 182 pneumothorax positive cases and 618 negative cases, with various confounding conditions. The EFAI PNXXR demonstrated high efficacy with a sensitivity of 0.97 and specificity of 0.98 for detecting pneumothorax, achieving an AUC of 0.99. The average processing time was 23.3 seconds, and subgroup analyses confirmed consistent performance across different demographics, X-ray manufacturers, data sources, and pneumothorax characteristics, including cases with image quality issues or other radiologic findings.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the algorithm differentiate between true pneumothorax and common mimics or confounding factors like blebs, bullae, or skin folds, particularly in subtle or small pneumothoraces?; What was the specific range of pneumothorax sizes (e.g., small, moderate, large, tension) included in the validation dataset, and did the device's sensitivity and specificity vary significantly across these different sizes?; The "Others" category for X-ray manufacturers showed a notably lower specificity (0.81); could you elaborate on which specific manufacturers fell into this category and any hypotheses for this performance discrepancy, such as image processing variations?; What specific deep learning architecture (e.g., CNN type, layers) is utilized by EFAI PNXXR, and what were the key characteristics of the dataset used for its initial training and internal validation (e.g., size, diversity, annotation methodology)?; How does the EFAI PNXXR system handle images with significant artifacts, suboptimal patient positioning, or poor technical quality, and what is its reported failure rate or mechanism for flagging images as unanalyzable to the user?